Iran revives cyclotron facility to strengthen domestic cancer treatment
Iranian nuclear industry specialists have restored a domestically operated cyclotron accelerator used to produce radioisotopes for the diagnosis and treatment of cancer, according to Iranian state media.
The development is expected to strengthen Iran’s capacity to produce medical radioisotopes locally and reduce its dependence on imported materials used in cancer care.
Read Also: Iran produces first domestically manufactured 200MW generator rotor shaft
A cyclotron is a type of particle accelerator that can be used to produce radioactive isotopes for medical applications, including nuclear medicine procedures used to diagnose and treat certain cancers.
Iranian officials said the country plans to expand its cyclotron network to seven centres by the end of the Seventh Development Plan in March 2029. The expansion is intended to increase domestic production of medical radioisotopes and improve access to nuclear medicine services.
According to the report, Iranian Atomic Energy Organization chief Mohammad Eslami said domestically produced radiopharmaceuticals cost about one-tenth of their imported equivalents, potentially lowering treatment costs for patients while strengthening the country’s self-reliance in medical supplies.
Read Also: Iran plans 5,000MW solar power plant in Isfahan
The revival of the cyclotron comes as Iran continues efforts to develop civilian applications of nuclear technology, particularly in medicine. Nuclear science and technology are widely used internationally in cancer diagnosis and treatment, including through the production of medical radioisotopes.
Iran’s planned expansion of its cyclotron facilities is therefore expected to play a growing role in the country’s cancer-care infrastructure, while supporting its broader push for domestic production of nuclear medicine products.
Follow the Neptune Prime channel on WhatsApp:
Do you have breaking news, interview request, opinion, suggestion, or want your event covered? Email us at neptuneprime2233@gmail.com





